Target
Glucose-dependent insulinotropic receptor
Ligand
BDBM50523028
Substrate
n/a
Meas. Tech.
ChEMBL_1888841 (CHEMBL4390518)
EC50
31±n/a nM
Citation
 Harada, KMizukami, JWatanabe, TMori, GUbukata, MSuwa, KFukuda, SNegoro, TSato, MInaba, T Optimization of oxadiazole derivatives with a spirocyclic cyclohexane structure as novel GPR119 agonists. Bioorg Med Chem Lett 29:2100-2106 (2019) [PubMed]  Article 
Target
Name:
Glucose-dependent insulinotropic receptor
Synonyms:
G-protein coupled receptor 119 (GPR119) | GP119_HUMAN | GPR119 | Glucose-dependent insulinotropic receptor
Type:
Protein
Mol. Mass.:
36901.49
Organism:
Homo sapiens (Human)
Description:
Q8TDV5
Residue:
335
Sequence:
MESSFSFGVILAVLASLIIATNTLVAVAVLLLIHKNDGVSLCFTLNLAVADTLIGVAISGLLTDQLSSPSRPTQKTLCSLRMAFVTSSAAASVLTVMLITFDRYLAIKQPFRYLKIMSGFVAGACIAGLWLVSYLIGFLPLGIPMFQQTAYKGQCSFFAVFHPHFVLTLSCVGFFPAMLLFVFFYCDMLKIASMHSQQIRKMEHAGAMAGGYRSPRTPSDFKALRTVSVLIGSFALSWTPFLITGIVQVACQECHLYLVLERYLWLLGVGNSLLNPLIYAYWQKEVRLQLYHMALGVKKVLTSFLLFLSARNCGPERPRESSCHIVTISSSEFDG
  
Inhibitor
Name:
BDBM50523028
Synonyms:
CHEMBL4456673
Type:
Small organic molecule
Emp. Form.:
C23H31FN2O5S
Mol. Mass.:
466.566
SMILES:
CC(O[C@H]1CC[C@]2(CC(C)(C)CO2)CC1)c1nc(no1)-c1ccc(CS(C)(=O)=O)c(F)c1 |r,wU:6.12,3.2,(72.12,-46.46,;72.13,-48,;73.54,-48.62,;74.79,-47.72,;74.63,-46.19,;75.89,-45.28,;77.3,-45.92,;78.79,-46.31,;79.62,-45.02,;80.96,-44.23,;80.96,-45.78,;78.66,-43.82,;77.22,-44.38,;77.45,-47.46,;76.2,-48.35,;70.89,-48.9,;69.42,-48.43,;68.51,-49.68,;69.42,-50.93,;70.89,-50.44,;66.97,-49.68,;66.2,-48.34,;64.66,-48.35,;63.89,-49.68,;62.36,-49.68,;61.58,-48.35,;60.05,-48.36,;61.97,-46.86,;63.07,-47.95,;64.66,-51.01,;63.89,-52.34,;66.2,-51.01,)|
Structure:
Search PDB for entries with ligand similarity: